Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1060051

registered interest
date	12/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to make immunoglobulin therapy available for the treatment of Mast Cell Activation Syndrome.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	220333
answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>Immunoglobulins are not currently licensed for the treatment of Mast Cell Activation Syndrome (MCAS). However, immunoglobulin therapy may be used ‘off-label’, if there are no other alternative licensed products available and the physician considers that immunoglobin therapy is appropriate to address the clinical need in order to manage a patient with MCAS. This decision, under the full responsibility of the physician, will need to be made following discussion between the physician and the patient.</p><p> </p><p>In order to gain a licence for the use of immunoglobulin therapy for the treatment of MCAS, a Marketing Authorisation Holder would have to submit a variation to their Marketing Authorisation to the Medicines and Healthcare products Regulatory Agency (MHRA) with a dossier compiled of safety and efficacy data. Specialist assessors would review the dossier and a variation to the Marketing Authorisation would only be granted if it is determined that the benefits of the product outweigh any potential risks of using the product in its proposed indication.</p><p> </p><p>The MHRA provides a scientific advice service to Marketing Authorisation Holders regarding their submissions should they request it.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/02/2019 16:45:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4679 label Biography information for Neil O'Brien

1015562

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nusinersen
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on its appraised criteria to facilitate progress towards a Managed Access Arrangement for Spinraza.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	196306
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Departmental officials have had a number of discussions with colleagues in the National Institute for Health and Care Excellence (NICE) to enquire about progress of the ongoing appraisal of nusinersen (Spinraza) for the treatment of spinal muscular atrophy. Discussions between NHS England, NICE and Biogen (the company that manufactures nusinersen) are ongoing to seek to agree a commercial agreement that would enable NICE to recommend use of nusinersen as a clinically and cost effective use of National Health Service resources.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:27:43 answering member 4067 label Biography information for Steve Brine
tabling member	4679 label Biography information for Neil O'Brien

938464

registered interest
date	11/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on the provision of Focused Laser Ablation treatment for prostate cancer available on the NHS.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	163225
answer	answer is ministerial correction date of answer 17/07/2018 answer text <p>Focused Laser Ablation treatment for prostate cancer is not within the scope of services commissioned by NHS England. We continue to encourage clinical commissioning groups and providers to offer services in line with the latest National Institute for Health and Care Excellence guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/07/2018 15:02:13 answering member 4067 label Biography information for Steve Brine
tabling member	4679 label Biography information for Neil O'Brien

758728

registered interest
date	07/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospital Wards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many neonatal units have the recommended amount of overnight parent accommodation to meet the standards outlined in the toolkit for high quality neonatal services; and what resources are provided to NHS trusts to increase the provision of overnight parent accommodation in places where that standard is not met.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	9562
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>As part of a review into neonatal critical care, NHS England is currently in the process of collating information on the availability of parent accommodation in hospitals and neonatal units, as an important part of the service specification. Individual National Health Service providers are responsible for providing this service within the current contractual arrangements. NHS England are visiting every trust as part of the Quality Surveillance Team reviews.</p><p> </p><p>The Neonatal Critical Care Review is to make recommendations that will support the delivery of high quality, safe, sustainable and equitable models of neonatal care across England. It will be presenting a draft review report to NHS England in October 2017. The draft report will be then be consulted upon before being finalised. The Neonatal Critical Care Review has already set out a range of themes that are to be factored into Local Maternity Systems’ Transformation Plans.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 9331 question first answered 12/09/2017 14:55:14 answering member 1542 label Biography information for Philip Dunne
tabling member	4679 label Biography information for Neil O'Brien

758743

registered interest
date	07/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospital Wards: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure equal access to overnight rooms or bed-space next to their child for parents saying overnight with their child in a paediatric ward and parents staying overnight with their baby in a neonatal unit.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	9331
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>As part of a review into neonatal critical care, NHS England is currently in the process of collating information on the availability of parent accommodation in hospitals and neonatal units, as an important part of the service specification. Individual National Health Service providers are responsible for providing this service within the current contractual arrangements. NHS England are visiting every trust as part of the Quality Surveillance Team reviews.</p><p> </p><p>The Neonatal Critical Care Review is to make recommendations that will support the delivery of high quality, safe, sustainable and equitable models of neonatal care across England. It will be presenting a draft review report to NHS England in October 2017. The draft report will be then be consulted upon before being finalised. The Neonatal Critical Care Review has already set out a range of themes that are to be factored into Local Maternity Systems’ Transformation Plans.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 9562 question first answered 12/09/2017 14:55:14 answering member 1542 label Biography information for Philip Dunne
tabling member	4679 label Biography information for Neil O'Brien

758764

registered interest
date	07/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Centres: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to encourage the provision of hoists in health centres to help transfer patients to examination beds.
tabling member constituency	Harborough
tabling member printed	Neil O'Brien
uin	9387
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>General practitioner practices are required to comply with the provisions in the Equality Act 2010 – including the requirement to make reasonable adjustments.</p><p> </p><p>Wherever possible, we would expect health centres to take into account the needs of their patients, and make reasonable adjustments for those individuals who have restricted mobility and may need assistance with movement during an examination.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2017 16:31:04 answering member 4067 label Biography information for Steve Brine
tabling member	4679 label Biography information for Neil O'Brien